Investors.iobiotech.com

IO Biotech to Present at 44th Annual Cowen Health Care Conference

WEBNEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) - IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic …

Actived: 5 days ago

URL: https://investors.iobiotech.com/news-events/news/news-details/2024/IO-Biotech-to-Present-at-44th-Annual-Cowen-Health-Care-Conference/default.aspx

IO Biotech, Inc. Announces $75 Million Private Placement Financing

WEBOffering includes participation from both new and existing healthcare-dedicated investors Proceeds extend the company’s cash runway into the fourth quarter …

Category: Health Go Health

IO Biotech, Inc.

WEB- Preclinical data showing the rationale for two new pipeline candidates targeting the immunosuppressive effects of Arginase-1 (ARG1) and Transforming …

Category: Health Go Health

IO Biotech to Present at 42nd Annual Cowen Healthcare Conference

WEBNEW YORK, March 04, 2022 (GLOBE NEWSWIRE) - IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer …

Category: Cancer Go Health

IO Biotech Announces Invited Oral Presentation and Two Poster

WEBNEW YORK, Oct. 05, 2022 (GLOBE NEWSWIRE) - IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer …

Category: Cancer Go Health

IO Biotech Appoints Heidi Hunter to its Board of Directors

WEBNEW YORK, Aug. 11, 2023 (GLOBE NEWSWIRE) - IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer …

Category: Cancer Go Health

IO Biotech, Inc.

WEBMission: Establish our T-win® immune-modulating cancer vaccine as the backbone of combination therapy for people with cancer.

Category: Cancer Go Health

IO Biotech, Inc.

WEBExecutive Management. – Dr. Zocca has served as our founder and Chief Executive Officer since January 2015. Dr. Zocca was also the founder and Chief Executive Officer of …

Category: Health Go Health

IO Biotech, Inc.

WEBBoard of Directors. Peter Hirth, Ph.D. Chairman. Dr. Hirth has served as Chairman of our board of directors since September 2016. Dr. Hirth founded Plexxikon, Inc., a …

Category: Health Go Health

IO Biotech, Inc.

WEBDr. Ahmad is a trained internist and clinical oncologist and brings over two decades of successful strategic clinical development, medical affairs, and marketing authorization …

Category: Medical Go Health

IO Biotech, Inc.

WEBCopenhagen, Denmark April 30, 2019: IO Biotechs CEO, Mai-Britt Zocca, Ph.D., will participate in a panel discussion entitled, IO Session I: Combination Failures Futures: …

Category: Health Go Health

IO Biotech, Inc.

WEBCopenhagen, Denmark January 13, 2021: IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune-modulating anti-cancer therapies based on its …

Category: Cancer Go Health

IO Biotech Hosting Key Opinion Leader Webinar Series

WEBPart 1: A New Way to Kill TumorsIO102-IO103 Phase 3 Trial in Combination with Anti-PD-1 in Advanced Melanoma Thursday, April 28 th @ 12:30pmET NEW …

Category: Health Go Health

IO Biotech, Inc.

WEBMs. Hunter has served on our board of directors since August 2023. Ms. Hunter most recently served as President of Cardinal Health where she led the Specialty Solutions …

Category: Health Go Health

IO Biotech, Inc.

WEBCopenhagen, Denmark July 5, 2021: IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune-modulating anti-cancer therapies based on its …

Category: Cancer Go Health

IO Biotech to Participate in March 2023 Investor Conferences

WEBNEW YORK, Feb. 22, 2023 (GLOBE NEWSWIRE) - IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer …

Category: Cancer Go Health